Sarepta Therapeutics, Inc. (SRPT) Financials

SRPT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 3.2 billion 1.7 billion
Dec. 31, 2025 3.3 billion 2.2 billion
Sept. 30, 2025 3.5 billion 2.2 billion
June 30, 2025 3.7 billion 2.3 billion

SRPT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -204.8 million 29.4 million
Dec. 31, 2025 125.4 million 30.0 million
Sept. 30, 2025 -42.8 million 14.9 million
June 30, 2025 229.4 million 37.0 million

SRPT Net Income

No data available :(

SRPT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 653.2 million 838.2 million 198.5 million
Dec. 31, 2025 939.7 million 829.0 million 199.4 million
Sept. 30, 2025 851.0 million 1.0 billion 215.0 million
June 30, 2025 800.1 million 1.1 billion 214.4 million

SRPT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 121.9 million
Dec. 31, 2025 104.8 million
Sept. 30, 2025 100.2 million
June 30, 2025 106.6 million

SRPT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2.1 million 154.0 million 109.0 million -
Dec. 31, 2025 5.8 million 325.3 million 128.3 million -
Sept. 30, 2025 28.2 million 218.9 million 91.9 million -
June 30, 2025 32.0 million 204.4 million 137.9 million -

SRPT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 730.8 million 119.4 million
Dec. 31, 2025 442.9 million 398.7 million
Sept. 30, 2025 399.4 million 150.8 million
June 30, 2025 611.1 million 152.6 million

SRPT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SRPT

Price: $15.67

52 week price:
10.42
25.32

Earnings Per Share: 0.35 USD

P/E Ratio: 55.43

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 366531

Ebitda: -43.3 million

Market Capitalization: 2.0 billion

Links: